Intra-Cellular Therapies Inc (ITCI)
85.56
-0.13
(-0.15%)
USD |
NASDAQ |
Nov 25, 14:00
Intra-Cellular Therapies Total Assets (Quarterly): 1.324B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.324B |
| June 30, 2024 | 1.321B |
| March 31, 2024 | 747.04M |
| December 31, 2023 | 728.30M |
| September 30, 2023 | 717.66M |
| June 30, 2023 | 713.60M |
| March 31, 2023 | 722.16M |
| December 31, 2022 | 754.78M |
| September 30, 2022 | 782.00M |
| June 30, 2022 | 811.91M |
| March 31, 2022 | 868.58M |
| December 31, 2021 | 489.92M |
| September 30, 2021 | 556.98M |
| June 30, 2021 | 625.70M |
| March 31, 2021 | 674.49M |
| December 31, 2020 | 717.31M |
| September 30, 2020 | 771.29M |
| June 30, 2020 | 440.93M |
| March 31, 2020 | 481.24M |
| December 31, 2019 | 251.19M |
| September 30, 2019 | 280.52M |
| June 30, 2019 | 309.86M |
| March 31, 2019 | 342.97M |
| Date | Value |
|---|---|
| December 31, 2018 | 357.21M |
| September 30, 2018 | 385.59M |
| June 30, 2018 | 412.07M |
| March 31, 2018 | 445.64M |
| December 31, 2017 | 471.49M |
| September 30, 2017 | 334.19M |
| June 30, 2017 | 349.54M |
| March 31, 2017 | 372.29M |
| December 31, 2016 | 388.90M |
| September 30, 2016 | 542.57M |
| June 30, 2016 | 447.60M |
| March 31, 2016 | 463.66M |
| December 31, 2015 | 484.10M |
| September 30, 2015 | 513.12M |
| June 30, 2015 | 213.40M |
| March 31, 2015 | 237.13M |
| December 31, 2014 | 131.11M |
| September 30, 2014 | 137.61M |
| June 30, 2014 | 141.34M |
| March 31, 2014 | 146.64M |
| December 31, 2013 | 38.45M |
| September 30, 2013 | 47.34M |
| June 30, 2013 | 0.00 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
251.19M
Minimum
Dec 2019
1.324B
Maximum
Sep 2024
725.00M
Average
719.91M
Median
Total Assets (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 3.081B |
| AbbVie Inc | 143.42B |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 179.62M |
| Shareholders Equity (Quarterly) | 1.145B |
| Current Ratio | 7.656 |